Identification of liver-specific enhancer–promoter activity in the 3′ untranslated region of the wild-type AAV2 genome
出版年份 2017 全文链接
标题
Identification of liver-specific enhancer–promoter activity in the 3′ untranslated region of the wild-type AAV2 genome
作者
关键词
-
出版物
NATURE GENETICS
Volume 49, Issue 8, Pages 1267-1273
出版商
Springer Nature
发表日期
2017-06-19
DOI
10.1038/ng.3893
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV
- (2016) Jean-Charles Nault et al. MOLECULAR THERAPY
- Reply to “Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV”
- (2016) Manfred Schmidt et al. MOLECULAR THERAPY
- Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
- (2016) Thomas Gaj et al. MOLECULAR THERAPY
- Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?
- (2016) Randy J Chandler et al. MOLECULAR THERAPY
- Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients
- (2016) Irene Gil-Farina et al. MOLECULAR THERAPY
- Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBactransposase gene delivery system
- (2015) Sharon C. Cunningham et al. HEPATOLOGY
- Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
- (2015) Kenneth I. Berns et al. HUMAN GENE THERAPY
- Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal Perspective
- (2015) Eric Hastie et al. HUMAN GENE THERAPY
- Adeno-associated Vector Toxicity—To Be or Not to Be?
- (2015) Hildegard Büning et al. MOLECULAR THERAPY
- Adeno-associated virus finds its disease
- (2015) David W Russell et al. NATURE GENETICS
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth
- (2014) Samina Alam et al. CANCER BIOLOGY & THERAPY
- AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy
- (2014) R Thwaite et al. GENE THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
- (2013) Koichiro Tamura et al. MOLECULAR BIOLOGY AND EVOLUTION
- Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
- (2013) Leszek Lisowski et al. NATURE
- Analysis Tool Web Services from the EMBL-EBI
- (2013) Hamish McWilliam et al. NUCLEIC ACIDS RESEARCH
- AAV-mediated gene targeting methods for human cells
- (2011) Iram F Khan et al. Nature Protocols
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS
- (2009) M A Zanta-Boussif et al. GENE THERAPY
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Sexually Dimorphic Patterns of Episomal rAAV Genome Persistence in the Adult Mouse Liver and Correlation With Hepatocellular Proliferation
- (2009) Allison P Dane et al. MOLECULAR THERAPY
- AAV2/8-mediated Correction of OTC Deficiency Is Robust in Adult but Not Neonatal Spfash Mice
- (2009) Sharon C Cunningham et al. MOLECULAR THERAPY
- Gene Delivery to the Juvenile Mouse Liver Using AAV2/8 Vectors
- (2008) Sharon C Cunningham et al. MOLECULAR THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started